Abstract
The challenge of nanotoxicology implies development of new methods and improvements of current ones to study the interface of nanomaterials and toxicological science. The nanoscale of materials provides new insights regarding their effects to cells, tissues, and organisms. The blood biocompatibility of nanomaterials is in the light of medical applications and hemolysis assay is pointed out as an important tool to bring toxicological information. Cell membrane disruption by nanomaterials is easily detected by free hemoglobin from red blood cells (RBCs), called erythrocytes. Moreover, nanomaterials’ physicochemical properties play a key role for understanding erythrocyte toxicity as well as their biomolecular surface chemistry interactions in biological fluids. In this way, this chapter aims to give an overview of nanomaterials toxicity to RBCs, focusing the current methods in nanotoxicology and exploring the advances in bionanointerface.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (eds) (2007) Molecular biology of the cell, 5th edn. Garland Science, New York
Ashby MF, Ferreira PJ, Schodek DL (2009) Nanomaterials, nanotechnologies and design: an introduction for engineers and architect, 1st edn. Butterworth-Heinemann, Oxford, UK
ASTM (2008) Standard test method for analysis of hemolytic properties of nanoparticles E2524-08
Barshtein G, Arbell D, Yedgar S (2011) Hemolytic effect of polymeric nanoparticles: role of albumin. IEEE Trans Nanobioscience 10(4):259–261
Brazhe NA, Abdali S, Brazhe AR et al (2009) New insight into erythrocyte through in vivo surface-enhanced raman spectroscopy. Biophys J 97(12):3206–3214
Chandra S, Das P, Bag S et al (2011) Synthesis, functionalization and bioimaging applications of highly fluorescent carbon nanoparticles. Nanoscale 3:1533–1540
Choi J, Reipa V, Hitchins VM et al (2011) Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol Sci 123(1):133–143
Creanga DE, Culea M, Nadejde C et al (2009) Magnetic nanoparticle effects on the red blood cell. J Phys Conf 170(1):1–5
Dobrovolskaia MA, Clogston JD, Neun BW et al (2008) Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett 8(8):2180–2187
Dobrovolskaia MA, Patri AK, Zheng J et al (2009) Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein biding profiles. Nanomedicine 5:106–117
Fairbrother A, Fairbrother JR (2009) Are environmental regulations keeping up with innovation? a case study of the nanotechnology study. Ecotoxicol Environ Saf 72(5):1327–1330
Garabagiu S (2013) Gold nanorods-hemoglobin bio-conjugate: spectroscopy studies. J Mol Struct 1031:216–220
Gerashchenko BI, Gun’ko VM, Gerashchenko II et al (2002) Probing the silica surfaces by red blood cells. Cytometry 49(2):56–61
Grebowski J, Krokosz A, Puchala M (2013) Membrane fluidity and activity of membrane ATPases in human erythrocytes under the influence of polyhydroxylated fullerene. Biochim Biophys Acta 1828(2):241–248
Higashisaka K, Yoshioka Y, Yamashita K et al (2012) Hemopexin as biomarkers for analyzing the biological responses associated with exposure to silica nanoparticles. Nanoscale Res Lett 7(555):1–9
Hu C-MJ, Zhang L, Aryal S et al (2011) Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A 108(27):10980–10985
Huh AJ, Kwon YJ (2011) Nanoantibiotics: a new paradigm for treating infectious diseases using nanomaterials in the antibiotic resistant era. J Control Release 156(2):128–145
Khullar P, Singh V, Mahal A et al (2012) Bovine serum albumin bioconjugated gold nanoparticles: synthesis, hemolysis and cytotoxicity toward cancer cell lines. J Phys Chem C 116(15):8834–8843
Krug HF, Wick P (2011) Nanotoxicology: an interdisciplinary challenge. Angew Chem Int Ed 50(6):1260–1278
Kunzmann A, Andersson B, Thurnherr T et al (2011) Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 1810(3):361–373
Labarre D, Vauthier C, Chauvierre C et al (2005) Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticle decorated with a polysaccharidic brush. Biomaterials 26(24):5075–5084
Lin YS, Haynes C (2010) Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc 132(13):4834–4842
Liu YF, Yu JS (2010) In situ synthesis of high luminescent glutathione-capped CdTe/ZnS quantum dots with biocompatibility. J Colloid Interface Sci 351(1):1–9
Lu SL, Duffin R, Poland C et al (2009) Efficacy of simple short-term in vitro assays for predicting the potential of metal oxide nanoparticles to cause pulmonary inflammation. Environ Health Perspect 117(2):241–247
Lundqvist M, Stigler J, Elia G et al (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 105(38):14265–14270
Meng J, Cheng X, Liu J et al (2012) Effects of long and short carboxylated or aminated multiwalled carbon nanotubes on blood coagulation. PLoS One 7(7):e38995
Monopoli MP, Aberg C, Salvati A et al (2012) Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 7:779–786
Oberdorster G, Oberdorster E, Oberdorster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823–839
Omenn GS, Aebersold R, Paik YK (2007) HUPO plasma proteome project. Mol Cell Proteomics 6:2252–2253
Paula AJ, Martinez DST, Araujo Júnior RT et al (2012) Suppression of the hemolytic effect of mesoporous silica nanoparticle after protein corona interaction: independence of the surface microchemical environment. J Braz Chem Soc 23(10):1807–1814
Rogers EJ, Hsieh SF, Organti N et al (2008) A high throughput in vitro analytical approach to screen for oxidative stress potential exerted by nanomaterials using a biologically relevant matrix: human blood serum. Toxicol In Vitro 22(6):1639–1647
Rothen-Rutishauser BM, Schürch S, Haenni B et al (2006) Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol 40(14):4353–4359
Sharifi S, Behzadi S, Laurent S et al (2012) Toxicity of nanomaterials. Chem Soc Rev 41(6):2323–2343
Shi J, Hedberg Y, Lundin M et al (2012) Hemolytic properties of synthetic nano- and porous silica particles: the effect of surface properties and the protection by plasma corona. Acta Biomater 8(9):3478–3490
Slowing II, Wu CW, Vivero-Escoto JL et al (2009) Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 5(1):57–62
Song HS, Park TH (2011) Integration of biomolecules and nanomaterials: towards highly selective and sensitive sensors. Biotechnol J 6(11):1310–1316
Tenzer S, Docter D, Rosfa S et al (2011) Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 5(9):7155–7167
Valizadeh A, Mikaeili H, Samiei M et al (2012) Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Res Lett 7(1):480. doi:10.1186/1556-276X-7-480
Walkey CD, Chan WC (2012) Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 41(7):2780–2799
Yu T, Malugin A, Ghandehari H (2011) The impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 5(7):5717–5728
Zhang H, Dunphy DR, Jiang X et al (2012a) Processing pathway dependence of amorphous silica nanoparticle toxicity: colloidal vs. pyrolytic. J Am Chem Soc 134(38):15790–15804
Zhang QX, Xu X, Bertrand N et al (2012b) Interactions of nanomaterials and biological systems: implications to personalized nanomedicine. Adv Drug Deliv Rev 64(13):1363–1384
Zhao ML, Li DJ, Yuan L et al (2011a) Differences in cytocompatibility and hemocompatibility between carbon nanotubes and nitrogen-doped carbon nanotubes. Carbon 49(9):3125–3133
Zhao F, Zhao Y, Liu Y et al (2011b) Cellular uptake, intracellular trafficking and cytotoxicity of nanomaterials. Small 7(10):1322–1337
Zhao Y, Sun X, Zhang G et al (2011c) Interaction of mesoporous silica nanoparticles with human red blood cells membranes: size and surface effects. ACS Nano 2(5):1366–1375
Zook JM, MacCuspie RI, Locascio LE et al (2011) Stable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity. Nanotoxicology 5(4):517–530
Zook JM, Halter MD, Cleveland D et al (2012) Disentangling the effects of polymer coatings on silver nanoparticle agglomeration, dissolution, and toxicity to determine mechanisms of nanotoxicity. J Nanopart Res 14(1165):1–9
Acknowledgments
The authors thank CNPq, FAPESP, INCT-Imonat, and the Brazilian Nanotoxicology Network—CIGENANOTOX.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
de Luna, L.A.V., Martinez, D.S.T., Alves, O.L. (2014). Assessing the Erythrocyte Toxicity of Nanomaterials: From Current Methods to Biomolecular Surface Chemistry Interactions. In: Durán, N., Guterres, S., Alves, O. (eds) Nanotoxicology. Nanomedicine and Nanotoxicology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8993-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8993-1_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8992-4
Online ISBN: 978-1-4614-8993-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)